Evidence map›Paper›PMID 18301922›Full record

ArticleParasitology research2008

Genotyping of Cryptosporidium isolates from human clinical cases in Poland.

Anna Bajer, Małgorzata Bednarska, Simone M Cacciò, Beata Wolska-Kuśnierz, Edyta Heropolitanska-Pliszka, Ewa Bernatowska, Małgorzata Wielopolska, Anna Paziewska, Renata Welc-faleciak, Edward Siński

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Clinical cases ofJournal of veterinary research · 2026
    Article
  2. The First Evidence ofFrontiers in cellular and infection microbiology · 2019
    Article
  3. Article
  4. Review ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Review
  5. Review
  6. Cryptosporidium meleagridis: infectivity in healthy adult volunteers.The American journal of tropical medicine and hygiene · 2011
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Anna BajerDepartment of Parasitology, Faculty of Biology, University of Warsaw, Warsaw, Poland. anabena@biol.uw.edu.pl
Małgorzata Bednarska
Simone M Cacciò
Beata Wolska-Kuśnierz
Edyta Heropolitanska-Pliszka
Ewa Bernatowska
Małgorzata Wielopolska
Anna Paziewska
Renata Welc-faleciak
Edward Siński
University of Warsaw · PLChildren's Memorial Health Institute · PLChildren's Hospital · TNIstituto Superiore di Sanità · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptosporidium spp. infection is usually self-limited in immunocompetent hosts but can be severe and life threatening in children and in immunocompromised individuals including those with primary or acquired immunodeficiencies. One hundred and three faecal samples were collected from 35 hospitalised patients with different symptoms and tested for the presence of the parasite. Cryptosporidium oocysts were found in four of 35 patients (11.4%) using Ziehl-Neelsen staining of faecal smears and immunofluorescence assay, whereas 12 (34.3%) samples tested positive by nested polymerase chain reaction assay. Cryptosporidium DNA was detected in one bile sample but not in a liver tissue biopsy sample collected from a patient who suffered from sclerosing cholangitis. Sequence analysis of oocyst wall protein and beta-tubulin gene fragments revealed three different parasite species (Cryptosporidium hominis, Cryptosporidium meleagridis and Cryptosporidium parvum) in children with primary immunodeficiencies, whereas only C. parvum was found in immunocompetent individuals and in those with secondary immunodeficiencies. This study has revealed a high prevalence of Cryptosporidium infection in hospitalised patients in Poland and confirmed that molecular techniques enable a more sensitive detection of the parasite.

Indexed as

2-PyridinylmethylsulfinylbenzimidazolesAdultAnimalsChildCryptosporidiosisCryptosporidiumGastroenteritisGenotypeHumansImmunocompromised HostImmunologic Deficiency SyndromesLansoprazolePoland2-PyridinylmethylsulfinylbenzimidazolesLansoprazole

Identifiers

PMID18301922
OpenAlexW1985313699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.